Global Cataract Surgery Devices And Equipment Market

The surgical sutures and staples market consists of sales of surgical sutures and staples and related services. Surgical sutures and staples are medical devices used by surgeons to hold skin, internal organs, blood vessels, or any other tissues together after they have been severed during surgery. Sutures and staples hold incised body parts together until they are completely healed. The main types of surgical sutures and staples are surgical sutures and surgical staples. Surgical staples are specialized staples utilized in surgery in place of sutures to close skin wounds or connect or remove parts. The surgical staples include disposable surgical staplers and reusable surgical staplers. The surgical sutures are absorbable and non-absorbable. The various end-users are hospitals, ambulatory surgical centers (ASCS), and clinics. The global surgical sutures and staples market size is expected to grow from $11.1 billion in 2021 to $12.21 billion in 2022 at a compound annual growth rate (CAGR) of 10.0%. The global surgical suture and staple market size is then expected to grow to $16.66 billion in 2026 at a CAGR of 8.1%. The increase in the number of surgical procedures across the globe is an important driver for the surgical sutures and staples market. This is mainly because surgeries are an important treatment procedure used to repair an injury, relieve symptoms, restore function, remove diseased organs, or replace anatomical parts of the body. Moreover, surgeries are also performed under emergency conditions such as trauma, fracture, and acute infection. For instance, according to the US Department of Health & Human Services, there were 22 million surgeries performed in the US out of which 52.7% were in outpatient surgeries. It is estimated that 234 million surgeries are performed throughout the world every year. Increasing adoption of minimally invasive surgeries is a major restraint for the surgical sutures and staples market. Minimally invasive surgery is a surgical technique to operate with less damage to the body than the open surgery technique. It also involves less pain, shorter hospital stays, and fewer complications than open surgery. This has led to the increasing adoption of these surgeries. For instance, according to a Canada-based market research firm iData Research, more than 693,000 robotic-assisted procedures were performed in the USA, out of which around 86% were minimally invasive surgeries. The use of disposable surgical sutures and staple devices is an emerging trend in the surgical sutures and staples market. This is mainly due to heightened concerns regarding communicable infections associated with the use of reusable sutures and staple devices for surgeries. Disposable surgical sutures and staple devices are designed in such a way that they are discarded after one use and cannot be reused. In this regard, the Centers for Disease Control and Prevention (CDC) provides protocols to prevent the spread of pathogens and promotes the use of disposable devices. The FDA has classified surgical staples as class I medical devices and implantable surgical staples as class II medical devices. Class, I medical devices are those which do not require pre-marketing submissions to the FDA whereas the Class II category requires pre-marketing submissions. Moreover, the FDA has also stated some measures and protocols for the sterilization of these devices that should be strictly followed to avoid the risk of infections. Hence, the regulatory scenario related to surgical staplers will keep a check on the companies that manufacture these devices. In 2021, BD seals acquired the surgical sealant maker Tissuemed. This acquisition is providing the opportunity to equip surgeons with a more robust, highly integrated portfolio of surgical solutions. Tissuemed is a UK- based self-adhesive film company that is helping surgeons to close and seal sutured and stapled internal tissues. Major players in the surgical sutures and staples market are Ethicon Endo-Surgery Inc, Stryker Corporation, Smith & Nephew plc, Conmed Corporation, Medtronic plc, Johnson & Johnson, B.Braun Melsungen AG, Baxter International Inc, Alcon Laboratories Inc, and Dextera Surgical Inc. North America was the largest region in the surgical sutures and staples market in 2021. Western Europe was the second-largest region in the global surgical sutures and staples market. The regions covered in the global surgical sutures and staples market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical sutures and staples market include Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The global surgical sutures and staples market is segmented - 1) By Type: Surgical Sutures, Surgical Staples 2) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Clinics 3) By Surgical Suture: Absorbable, Non-Absorbable 4) By Surgical Staple: Disposable Surgical Staplers, Reusable Surgical Staplers

The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes, and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy, and reconstruction surgeries. The main products in ENT surgical devices and equipment are hand instruments, ENT surgical lasers, powered ENT surgical systems, radiofrequency electrosurgical devices, ENT surgery workstations, ENT surgical navigation system, ENT visualization system, and surgical microscopes. These devices and equipment are hand-held devices, portable devices, and fixed devices. The various end-users are hospitals, ambulatory surgical centers, and ENT clinics. The global ENT surgical devices and equipment market size is expected to grow from $4.69 billion in 2021 to $5.25 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The global ENT surgical devices market size is expected to grow to $7.95 billion in 2026 at a CAGR of 10.9%. Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offer patients many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In the majority of the cases, physicians enjoy a higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market. Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involve greater devices, and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market. ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring, and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot-assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with the ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted. The ENT surgical devices and equipment industry has lately witnessed a rise in the number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by the FDA, the FDA 510(K) is expected to see several updates to regulate safety, technology, and capabilities in the medical devices space. The European Union’s Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management. In 2020, Intersect ENT, a USA-based ear, nose, and throat condition treatment developer, announced to acquire Fiagon for USD 71.1 million. The acquisition was aimed to help Intersect ENT to expand its product portfolio and to extend its geographical reach. Fiagon develops surgical navigation systems that support both routine and complex ENT procedures and is based in Germany. Major players in the ENT surgical devices and equipment market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd, KLS Martin LP, Acclarent Inc, Medtronic, Smith & Nephew, Boston Scientific, Olympus, and ClaroNav. Asia Pacific was the largest region in the ENT surgical devices and equipment market in 2021. North America was the second-largest region in the global ENT surgical equipment market. The regions covered in the global ENT surgical devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in ENT surgical devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The global ENT surgical devices and equipment market is segmented - 1) By Modality: Hand-Held Devices, Portable Devices, Fixed Devices 2) By End-User: Hospitals, Ambulatory Surgical Centers, ENT Clinics 3) By Product: Hand Instrument, ENT Surgical Lasers, Powered ENT Surgical Systems, Radiofrequency Electrosurgical Devices, ENT Surgery Workstations, ENT Surgical Navigation System, ENT Visualization System, Surgical Microscopes

The robotic surgery devices market consists of sales of robotic systems, instruments, and accessories and services related to the robotic surgery devices market. Robotic surgery devices are advanced surgical devices compared to traditional laparoscopic surgery devices. These devices are used for Minimally Invasive (MI) surgeries in the eye, brain, heart, and other parts of the body. The robotic surgery devices are more cost-effective and introduced to reduce complications, pain, reoperations, etc. The main product and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centers. The global robotic surgery devices market size is expected to grow from $5.21 billion in 2021 to $6 billion in 2022 at a compound annual growth rate (CAGR) of 15.2%. The global robotic surgery device market size is expected to grow to $10.17 billion in 2026 at a CAGR of 14.1%. The rise in demand for minimally invasive technology is driving the robotic surgery devices market. Minimally Invasive (MI) surgery devices are equipped with imaging and catheter technologies that can be easily inserted into any part of the body. Robotic surgery procedures are usually associated with minimally invasive surgeries. These technologies are mainly used for heart, laparoscopy, orthopedic, gynecological, and urological surgeries. Robotic surgeries were introduced to reduce patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to the Intuitive Surgical company report, there is a 24% growth year on year for instruments and accessories. For robotic systems, the company has gained 16% growth and the overall robotic surgery devices market is growing at a rate of 13% -16%. The Intuitive Surgical company estimates that more than 1.2 million surgical procedures were done by using their robotic systems. Consumer preferences are changing and hospitals are adopting robotic surgery devices to create more value and cost-effective surgical procedures. Expensive robotic surgery is hampering the robotic surgery devices market. Robotic surgery is comparatively more expensive than other traditional ways of surgeries as it is associated with a lot of complications, requires highly trained senior doctors to operate robotic systems/instruments, complex technical operations, and maintenance. A single robotic system costs around $2 million and the surgery costs about a range of $3000 - $6000. The annual maintenance cost of robotic surgery devices usually costs between $100,000 - $170,000. The largest robotic surgery device manufacturer Intuitive Surgical supplies the single-use or disposable surgical tools used for robotic arms for surgeries. This is one of the reasons that robotic surgeries are more costly. The huge cost associated with robotic surgeries is therefore hindering the market growth. The advances in surgical products and technologies in the health care industry are creating more opportunities in the robotic surgery devices market. Increasing investments in R&D is helping investors to create value for the customers by producing medical-surgical products like robotic surgery devices by using the latest technologies. With the use of robotic systems that are equipped with optical imaging, surgical tools, instruments, and accessories, the surgeries are made easier. Some of the surgical advances that are creating more value and opportunity in the healthcare industry include 3-D high definition endoscope (Multi-Angle Rear-Viewing Endoscopic tool) devices for Brain surgery, Smart surgical glasses (equipped with a video camera and Head-mounted monitor) that act like computers, and can use for live observation of surgeries, surgical robots with artificial intelligence that acts as doctors, and humanoid robots which are used for highly critical surgeries in eye and brain. The other advanced surgical tool is remote robotics, which is used to assist with surgery from any remote location. Therefore, robotic surgery devices are playing an important role in the healthcare industry with their technological advancements and innovations. In July 2019, Intuitive Surgical Inc., an American corporation that develops, manufactures, and markets robotic products, acquired Schölly Fiberoptic’s robotic endoscope business. Schölly Fiberoptic is a major player in the visualization systems for Minimally Invasive (MI) diagnostic and surgical applications. This acquisition integrated Schölly’s robotic endoscope manufacturing line, and two Schölly sites into some of the Intuitive operations which are the robotic-related manufacturing line from Denzlingen (Germany), the manufacturing site in Biebertal (Germany), and the repair site in Worcester, Mass (USA). The acquisition's main aim is to strengthen Intuitive’s supply chain and increase its manufacturing capacity for visualization products to advance healthcare. Major players in the robotic surgery devices market are Intuitive Surgical, Stryker, Medtronic, Smith & Nephew, TransEnterix, Mazor Robotics, Medrobotics, Accuray, THINK Surgical, and TINAVI Medical Technology Co. Ltd. North America was the largest region in the robotic surgery devices market in 2021. Western Europe was the second largest market in the global robotic surgery device market. The regions covered in the global robotic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. The global robotic surgery devices market is segmented - 1) By Product and Service: Robotic Systems, Instruments and Accessories, Services 2) By Surgery Type: Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery, Others 3) By End-User: Hospitals, Ambulatory Surgery Centers

The surgical imaging arms market consists of sales of surgical imaging arms and related services by entities (organizations, sole traders, and partnerships) that manufacture surgical imaging arms, a vital component used in the field of surgery, especially for performing minimally invasive procedures. The revenue generated by the entities primarily engaged in research, development, manufacturing, and marketing of surgical imaging arms is included in the market. The main types of surgical imaging arms are G-arm surgical imaging devices, C-arm surgical imaging devices, and O-arm surgical imaging devices. The G-arm surgical imaging devices are fluoroscopic X-ray devices that are used for diagnostic imaging and minimally invasive surgical procedures. The various technology involved is image intensifier C-arms and flat-panel detector C-arms. The various application involved are orthopedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, and other applications. The end-users are hospitals and ambulatory surgical centers, and academic research institutes. The global surgical imaging arms market size is expected to grow from $1.15 billion in 2021 to $1.22 billion in 2022 at a compound annual growth rate (CAGR) of 6.0%. The global surgical imaging arm market size is expected to grow to $1.6 billion in 2026 at a CAGR of 7.0%. High demand for mini C-arms devices is expected to boost market growth during the forecast period. Globally, companies are engaged in the development and manufacturing of novel equipment that assists surgeons in carrying out surgical procedures smoothly and efficiently. The rising demand for mini C-arms devices can be attributed to features, such as its miniaturized size, easy adaptability in the operation theatre, and lower price than other types of C-arms. For instance, In September 2019, OrthoScan Inc. launched TAU 2020 Mini C-arm which introduces the largest screen on the mini C-arm. Minimally invasive tests or surgeries incur low costs and save between $280 million and $340 million in the USA alone by opting for it. With this, the doses can be saved by minimizing shots to enhance work efficiency. Thus, the rising demand for mini C-arms combined with its easy-to-use features is expected to drive market growth. The high cost of surgical imaging arms is anticipated to hamper market growth during the forecast period. Recently, the prices of surgical arms are increasing owing to constant research and development to introduce new features in the devices. The price of C-arm imaging devices ranges from $25,000 to greater than $70,000. The advanced C-arms such as Siemens Cios Fusion of Siemens Healthcare and OEC 9900 of GE Healthcare range between $1,50,000 and $2,00,000. The average refurbished mini C-arm price ranges between $19,000 and $50,000. Health care settings face challenges with the high costs of these devices that are predicted to hinder the market growth. Integration of technology for real-time visualization during surgeries is gaining significant popularity in the surgical imaging arms market. With the increasing number of patients requiring surgeries, the scope and complexity of surgical interventions such as image-guided minimally invasive surgery continue to surge. In January 2020, Philips announced major innovations in its Zenition mobile C-arm platform. With the new user interface, the clinician will be able to operate C-arm inside the sterile field, reducing the communication burden with the operator and making it more intuitive to control the system. Moreover, the platform is extended to integrate intravascular ultrasound (IVUS) for peripheral vascular procedures for improving workflow and streamlining the operating room. In 2019, FUJIFILM Corporation, Japan-based multinational photography, medical equipment, and biotechnology company that leverages its imaging and information technology for innovation in healthcare, graphic arts, optical devices, highly functional materials, and other high-tech areas, planned to acquire Hitachi's diagnostic imaging-related business for approximately $1.63 billion (JPY 179 Billion). Fujifilm will further expand its Medical Systems business by applying its proprietary image processing and AI technologies to Hitachi’s extensive product portfolio. Hitachi, Ltd., is a Japan-based multinational conglomerate company that provides solutions using a diagnostics imaging system, IT, and electronic health record. Major players in the surgical imaging arms market are GE Healthcare, Hologic Inc, ATON GmbH, Whale Imaging Inc, Siemens Healthcare, Shimadzu Corp, Canon Medical Systems Corporation, Medtronic plc, Ziehm Imaging, and Philips Healthcare. The regions covered in the global surgical imaging arms market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the surgical imaging market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global surgical imaging arms market is segmented - 1) By Product Type: G-Arm Surgical Imaging Devices, C-Arm Surgical Imaging Devices, O-Arm Surgical Imaging Devices 2) By Technology: Image Intensifier C-Arms, Flat Panel Detector C-Arms 3) By Application: Orthopaedic and Trauma Surgeries, Neurosurgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries, Others 4) By End-User: Hospitals and Ambulatory Surgical Centers, Academic Research Institutes

The surgical sealants and adhesives market consists of revenue generated from the sales of surgical sealants and adhesives. Surgical sealants and adhesives are materials used to repair injured tissues and prevent air and fluid leakages during or after the surgeries. These are used for minimizing blood losses, replacing staples and sutures for better closure, and strengthening wound areas without limiting tissue movement. The surgical sealants and adhesives market covered in this report is segmented by product into biological sealants, synthetic sealants, and semi-synthetic sealants. The biological sealants are made up of biological material that is used to repair injured tissues and prevent air and fluid leakages during or after the surgeries These are used for various indications such as tissue sealing, tissue engineering, and hemostasis that are used by end-uses such as hospitals, clinics, and others. The global surgical sealants and adhesives market size is expected to grow from $2.12 billion in 2021 to $2.39 billion in 2022 at a compound annual growth rate (CAGR) of 13.0%. The global surgical sealant and adhesive market is expected to grow to $3.13 billion in 2026 at a CAGR of 6.9%. The rising number of surgical procedures is predicted to contribute to the growth of the surgical sealants and adhesives market. In recent years, the continuous surge in surgical procedures is registered attributing to the growing prevalence of obesity and other lifestyle diseases, increasing incidence of spinal and sports-related injuries, and rising geriatric population. The old-age population is more prone to chronic, heart, and other diseases, thereby undergoing surgical procedures. According to the United Nations Department of Economic and Social Affairs, the number of people over the age of 65 is projected to increase from 703 million in 2019 to 1.5 billion by 2050, globally. The advances in surgical procedures are anticipated to hinder the growth of the surgical sealants and adhesives market. Minimal invasive surgeries are replacing conventional surgical procedures, eliminating complications including bleeding and air leakage and therefore, limiting the use of any surgical sealants and adhesives. According to the American Society of Plastic Surgeons (ASPS), approximately 18 million people undergoing surgical and minimally invasive cosmetic procedures in the USA. Hence, the growing number of minimally invasive surgeries and other substitutes for conventional surgical processes is predicted to impact the growth of the market over the forthcoming years. Several companies operating in the market are focusing on product portfolio expansion into untapped geographies. For instance, in January 2020, Terumo Corporation announced the launch of AQUABRID, a new surgical sealant in the EMEA market. AQUABRID is specially developed for aortic procedures to stop bleeding during and post surgeries. The company earlier introduced this product in Japan under the brand name Hydrofit and is under the process of registration in Eastern Europe, the Middle East, and Africa. In January 2019, Advanced Medical Solutions Group is a UK based developer and manufacturer of innovative and technologically advanced products for the wound care, surgical, and wound closure markets acquired Sealantis for $25 million in cash and royalties. The acquisition provides AMS with a technology platform and delivery systems that hold significant potential over a range of applications in the high-margin internal surgery market which includes the $1 billion internal sealant market. Sealants are an Israel-based medical device company with a patent-protected alga-mimetic sealants technology platform. Major players in the global surgical sealants and adhesives market are Baxter International Inc., B. Braun Melsungen AG, Cohera Medical, Inc., CryoLife Inc., C.R. Bard Inc., CSL Limited (CSL Behring), Johnson & Johnson (Ethicon, Inc.), Sanofi, Ocular Therapeutix Inc., and Sealantis Ltd. The regions covered in the global surgical sealants and adhesives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the global surgical sealants and adhesives report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The global surgical sealants and adhesives market is segmented - 1) By Product: Biological Sealants, Synthetic Sealants, Semi-Synthetic Sealants 2) By Indication: Tissue Sealing, Tissue Engineering, Hemostasis 3) By End-Use: Hospitals, Clinics, Others

The minimally invasive surgery devices market consists of sales of minimally invasive surgical devices and related services. The minimally invasive surgery devices are used to minimize the surgical incisions and trauma in the body. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices. The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centers (ASCS), and research institutes. The global minimal invasive surgery devices market size is expected to grow from $26.04 billion in 2021 to $28.98 billion in 2022 at a compound annual growth rate (CAGR) of 11.3%. The global minimal invasive surgery device market is expected to grow to $36.61 billion in 2026 at a CAGR of 6%. The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth. Many countries placed trade restrictions, especially on imports, to boost local production. For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The US is also implementing several trade restrictions, especially with China, to boost its local production. For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices. Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry. For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs. VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs. Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others. Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. In December 2019, FDA released a safety communication, regards the caution when using robotically-assisted minimally invasive surgical devices in women's health including mastectomy and other cancer-related surgeries. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer. Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC, Siemens Healthineers, Smith & Nephew Plc., Medtronic Plc., Stryker Corporation, Boston Scientific Corporation, Ethicon Inc, and B. Braun Melsungen AG. The regions covered in the global minimal invasive surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The global minimal invasive surgery devices market is segmented - 1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring and Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics and Gynecology, Ophthalmology, Neurosurgery, Urology, Others 3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Research Institutes

The surgical equipment market consists of sales of surgical equipment and related services by entities (organizations, sole traders, and partnerships) that produce surgical equipment used during surgeries. The main types in the surgical equipment are surgical sutures and staples, handheld surgical devices and equipment, electrosurgical devices, and equipment. The surgical sutures also known as stitches, are sterile surgical threads used to repair cuts. They are used to close incisions in surgery. Staples is a town used as a center for the sale or exportation of commodities in bulk. The type of expenditure is public, private. The products used are instruments/equipment, disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The global surgical equipment market size is expected to grow from $24.53 billion in 2021 to $26.89 billion in 2022 at a compound annual growth rate (CAGR) of 9.6%. The global surgical equipment market size is then expected to grow to $36.42 billion in 2026 at a CAGR of 7.9%. Growing demand for minimally invasive surgery (MIS) will increase the demand for advanced surgical equipment. An MIS refers to any surgical procedure that requires minimal incisions as opposed to traditional or open surgery used for the same purpose. Preference for MIS procedures increased due to their multiple advantages such as short healing and recovery time, minimal scarring, cost-effectiveness, minimal trauma and pain, and decreased risk of infections and complications. Medical technology innovations led to the development of advanced surgical equipment such as Da Vinci surgical systems, C-arm devices, electrosurgical and power-assisted surgical equipment. These devices which enable MIS will drive the surgical equipment market during the forecast period. Interest rates globally are forecasted to rise in most of the developing and developed economies, during the forecast period, this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, making it harder for companies in the surgical equipment market to raise funds for developing new devices thereby affecting the market growth. Surgical equipment manufacturers are offering next-generation ultrasonic surgical devices to simplify complex surgical procedures. Modern ultrasonic surgical devices are multifunctional instruments capable of performing tissue plane dissection, coagulation, and transection during laparoscopic or open surgical procedures. Next-generation ultrasonic devices feature adaptive tissue technology. In this technology ultrasonic algorithm actively monitors the condition of the tissue within the jaws of the device and allows the system to intelligently sense and respond to changes in patient tissue conditions. The system modulates energy delivery based on tissue thickness and tissue type to optimize vessel sealing and provide for secure and reliable large vessel sealing. Ethicon’s Harmonic devices feature adaptive tissue technology Major companies in the surgical equipment market include Johnson & Johnson (J&J), Stryker Corporation, Intuitive Surgical, B. Braun Melsungen AG, and Getinge Group. North America was the largest region in the global surgical equipment market in 2021. Western Europe was the second-largest region in the global surgical equipment market. The regions covered in the global surgical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the surgical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The global surgical equipment market is segmented - 1) By Type: Surgical Sutures and Staples, Handheld Surgical Devices and Equipment, Electrosurgical Devices and Equipment 2) By End-User: Hospitals and Clinics, Diagnostic Laboratories, Others 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

The electrosurgical devices market consists of sales of electrosurgical devices and related services. Electrosurgical devices include surgical generators and electrosurgical instruments Electrosurgical instruments include monopolar, bipolar and ultrasonic instruments. These devices deliver high-frequency electrical currents and voltages through an active electrode. They are used for cutting, sealing, and coagulating tissue during a variety of open and laparoscopic surgical procedures. The main products of the electrosurgical devices are electrosurgery generators, electrosurgery instruments and accessories, argon, and smoke management systems. Electrosurgery generators facilitate therapeutic endoscopy by supplying the high-frequency electrical current required to use endoscopic accessories. The applications involved are general surgery, gynecology surgery, urologic surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, and neurosurgery. The various end-users are hospitals, specialized clinics, and ambulatory surgery centers. The global electrosurgical devices and equipment market size is expected to grow from $7.93 billion in 2021 to $8.65 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%. The global electrosurgical devices market size is expected to grow to $11.54 billion in 2026 at a CAGR of 7.5%. The increasing prevalence rate of chronic diseases contributed significantly to the growth of the electrosurgical devices and equipment market. The electrosurgical devices are used in the surgery of many life-threatening diseases such as skin cancer, small basal cell carcinomas, squamous cell carcinoma, wound surgery, skin surgery, non-cancerous moles, dentistry, and others. There has been an increase in the number of skin diseases worldwide. For example, in the year 2019, according to one study conducted by the American Society of Clinical Oncology, around 2,000 people in the USA are diagnosed with Merkel cell carcinoma each year and this number has rapidly increased from past decades. According to WHO, the global burden of major chronic diseases currently accounts for 43% of all diseases and is set to rise to 60% by 2020. According to a United Nations’ report on world population aging, globally the 60+ aged population is projected to grow by 56% to reach 1.4 billion. The growth of the aging population and rising chronic disease incidence will contribute to increased hospitalization. The increase in the patient pool is expected to rise the demand for electrosurgical devices and equipment. The high incidence of product recalls is one of the factors restraining the electrosurgical devices and equipment market growth. The medical device industry is seeing a significant spike in product recalls during recent years due to defective devices, software issues, mislabeling issues, and quality issues. The electrosurgical devices and equipment market is a minor part of the medical device market and hence, product recall in the electrosurgical market is quite often. For example, in March 2019, Covidien, PLC, recalled its class 2 Covidien Force Traverse electrosurgical device due to bad sterile packaging. Zimmer Biomet, a medical device company recalled it is class 1 SPF PLUS-Mini and SPF XL IIB Implantable Spinal Fusion Stimulators due to high levels of potentially harmful chemicals which may be toxic to tissues and organs. FDA Safety Communication notice was Magellan Diagnostics and LeadCare of Meridian Bioscience, Inc. for its LeadCare Testing Systems for giving inaccurate test results. Electrosurgery is the application of a high-frequency electric current on biological tissue to create. Technological advances have led to the development of modern ESUs that deliver the medically useful thermal effect. This system is capable of continuously monitoring current and voltage, deriving parameters such as power and tissue resistance, and analyzing them. Depending on the desired treatment outcome, these devices can also keep the operating parameters constant or change them in a targeted manner through control and regulation. Electrosurgical equipment manufacturers should consider investing ESUs to increase market share in the market. The regulatory changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes are leading to increased costs of electrosurgical equipment product development and supply to healthcare services organizations. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. According to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR. In the USA, the U.S. Department of Health and Human Services and Center for Devices and Radiological Health are regulating electrosurgical devices under US FDA. There are two main ways that manufacturers can follow for premarket approval. One way consists of conducting clinical studies and submitting a premarket approval (PMA) application that includes evidence providing reasonable assurance that the device is safe and effective. The other way involves submitting a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. The FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The delays in product releases and additional costs incurred due to stringent approval processes put a strain on investments relating to electrosurgical equipment new product development resulting in potential loss of revenue. Major players in the electrosurgical devices market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen AG, Medtronic PLC, Smith and Nephew, Boston Scientific, Stryker Corporation, ATMOS Inc, Heal Force Bio-Meditech Holdings Limited, and Erbe Elektromedizin GmbH. North America was the largest region in the electrosurgical devices market in 2021. Western Europe was the second-largest region in the global electrosurgical devices market. The regions covered in the global electrosurgical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the electrosurgical devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The global electrosurgical devices and equipment market is segmented - 1) By Product: Electrosurgery Generators, Electrosurgery Instruments and Accessories, Argon and Smoke Management Systems 2) By End-User: Hospitals, Specialized Clinics, Ambulatory Surgery Centers 3) By Application: General Surgery, Gynecology Surgery, Urologic Surgery, Orthopedic Surgery, Cardiovascular Surgery, Cosmetic Surgery, Neurosurgery